Jonathan Yen, PhD, on Continuing Research With Prime Editing for Sickle Cell Disease
The director of therapeutic genome engineering, St. Jude Children’s Research Hospital discussed challenges with performing prime editing in cells.
Jonathan Yen, PhD, on Showing Proof-of-Concept With Prime Editing in Sickle Cell Disease
The director of therapeutic genome engineering, St. Jude Children’s Research Hospital discussed recent research published in Nature Biomedical Engineering.